Skip to main content

Table 2 Susceptibility of XMRV and HIV-1 to integrase inhibitors.

From: Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors

  EC50(nM)a
Inhibitor HIV-1NL4-3 XMRVVP62+LtatSNb XMRV22Rv1+LtatSNb
raltegravir 3.7 ± 2.1 2.1 ± 1.1 (1) 2.2 ± 1.1 (1)
elvitegravir 1.9 ± 0.7 150 ± 115 (79) 87 ± 29 (46)
  1. a EC50 values were measured in MAGIC-5A cells as described in Methods and are the means ± standard deviation from two or more independent experiments. Numbers in parentheses indicate the fold change in EC50 relative to HIV-1NL4-3. Values shown in bold are significantly different from the corresponding values for HIV-1NL4-3 (p < 0.05, ANOVA with Tukey's multiple comparison test).
  2. b XMRV-pseudotyped LtatSN virus. See text for details.